Dopexamine

This classification denotes a dopamine agonist and alpha-adrenergic agonist with the molecular formula C22H32N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 398E7Z7JB5, chemically known as 1,2-benzenediol, 4-(2-((6-((2-phenylethyl)amino)hexyl)amino)ethyl)- but generally known as dopexamine, which bears US NIH Compound Identifier 55483. European Medicines Agency schedules Dopexamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06366MIG. The term DOPEXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules dopexamine in its Anatomical Therapeutic Chemical (ATC) Classification. DOPEXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dopexamine under HS 29222900 and SITC 51462. As of Q4 2014, DOPEXAMINE remains the US FDA Preferred Term for this commodity. Dopexamine bears US NLM identifiers UMLS ID C0058702 and NCI Concept Code C75039. SMILES: OC1CC(CCNCCCCCCNCCC2CCCCC2)CCC1O.